T. Giezen

发表

T. Egberts, H. Leufkens, M. D. De Bruin, 2015, Expert opinion on drug safety.

N. Vermeer, T. Giezen, E. Wolff-Holz, 2019, Clinical pharmacology and therapeutics.

T. Giezen, M. Becker, S. V. van Lelyveld, 2021, Cardiovascular toxicology.

H. Gardarsdottir, T. Egberts, H. Leufkens, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

H. Gardarsdottir, J. Hoekman, T. Egberts, 2020, Clinical pharmacology and therapeutics.

M. Wadhwa, R. Thorpe, N. Ekman, 2012, Blood.

T. Egberts, H. Leufkens, S. Straus, 2012, European journal of haematology.

H. Gardarsdottir, T. Egberts, H. Leufkens, 2019, British journal of clinical pharmacology.

H. Leufkens, A. Mantel‐Teeuwisse, T. Giezen, 2009, Drug safety.

H. Gardarsdottir, T. Egberts, T. Giezen, 2021, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Leon van Aerts, Martina Weise, T. Giezen, 2017, BioDrugs.

H. Gardarsdottir, T. Egberts, H. Leufkens, 2021, Biologicals : journal of the International Association of Biological Standardization.

R. Meyboom, T. Egberts, H. Leufkens, 2010, Drug safety.

H. Leufkens, A. Mantel‐Teeuwisse, T. Giezen, 2010, Drug safety.

T. Giezen, M. Becker, R. V. D. van der Hoeven, 2020, International Journal of Clinical Pharmacy.

P. M. van den Bemt, T. Giezen, K. Meijer, 2020, European Journal of Clinical Pharmacology.

H. Gardarsdottir, T. Egberts, H. Leufkens, 2021, Pharmacology research & perspectives.